It is suggested to use peanut epicutaneous immunotherapy in children aged 4 to 11 years and oral allergen immunotherapy in children over 4 years of age in the case of severe IgE-mediated hen’s egg or cow’s milk allergy. This evidence concerns the gene IGHE and allergic disease.